𝔖 Bobbio Scriptorium
✦   LIBER   ✦

A phase II study of piritrexim in patients with advanced squamous cell carcinoma of the head and neck

✍ Scribed by Degardin, M.; Domenge, C.; Cappelaere, P.; Luboinski, B.; Navarrete, M.S.; Scott, J.E.; Lefebvre, J.-L.

Book ID
122341690
Publisher
Elsevier Science
Year
1994
Tongue
English
Weight
257 KB
Volume
30
Category
Article
ISSN
0959-8049

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

A phase II study of piritrexim in patien
A phase II study of piritrexim in patients with advanced squamous head and neck cancer
✍ Wu-Ching Uen; Andrew T. Huang; Robert Mennel; Stephen E. Jones; Monica B. Spauld πŸ“‚ Article πŸ“… 1992 πŸ› John Wiley and Sons 🌐 English βš– 347 KB πŸ‘ 3 views

Piritrexim (PTX) is a newly developed lipid-soluble folate antagonist that crosses the cell membrane by a simple, rapid, carrier-independent diffusion process. A Phase II study was conducted to evaluate the activity of PTX in 34 patients with previously chemotherapy-naive squamous cell cancer of the

Phase II study of mitoxantrone in advanc
Phase II study of mitoxantrone in advanced squamous cell carcinoma of the head and neck
✍ Stephen D. Williams; Robert Birch; Enrique Velez-Garcia; Richard Gams πŸ“‚ Article πŸ“… 1985 πŸ› Springer US 🌐 English βš– 170 KB

A phase II study of mitoxantrone in squamous cell carcinoma of head and neck origin was conducted. Fiftythree evaluable patients were treated with this agent at a dosage of 5 mg/M2/week. The majority of patients were of high performance status. Twenty-seven patients had received previous chemotherap